Background factors affecting the effectiveness of the COVID-19 vaccine and their association with the microbiomes in the oral cavity and intestinal tract
Not Applicable
- Conditions
- Regardless of the type of disease
- Registration Number
- JPRN-UMIN000043558
- Lead Sponsor
- Department of Pulmonology and Gerontology, Graduate School of Medicine, Yamaguchi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Not provided
Exclusion Criteria
Key exclusion criteria 1) Those who do not wish to be vaccinated with COVID-19 vaccine. 2) Those who have a history of COVID-19. 3) Those who are judged to be inappropriate for registration at the discretion of the doctor in charge.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relationship of immunogenicity (serum antibody titer to severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] and T-cell reactivity in peripheral blood mononuclear cells [PBMCs] to SARS-CoV-2 antigen) and its transition at 6 months and at 1 year after COVID-19 vaccination with the clinical background of subjects.
- Secondary Outcome Measures
Name Time Method